Essenlix Corporation is partnering with Roche Diagnostics Norway to implement Essenlix’s iMOSTTM platform for the Patient At-Home Test market. Ease mix corporation is a developer, manufacturer, and provider of mobile instant health test solutions for both personal and clinical use, providing the link between personal health, remote monitoring and treatment, and e-health services.
The Norwegian healthcare service is encountering crucial capacity challenges, with an increasing number of patients and elderly in need of health services, as well as a reduced supply of health personnel. To face these challenges and offer better healthcare, the Norwegian healthcare system is booting into a new period of medical distance follow-up and treatment, which requires innovative technologies that allow patients to perform safe, accurate, reliable, and easy-to-use healthcare tests at home.After evaluation and collaboration, Roche Diagnostics Norway has chosen Essenlix as its partner for the initiative and will employ Essenlix’s iMOST, a breakthrough technology in at-home diagnostic testing as the platform for its patient-at-home-test solution in Norway.
Essenlix iMOSTTM is an instant, mobile phone-based health test platform for personal, point-of-care, and clinical use. It is designed to allow any person to perform a diagnostic health test for themselves accurately, anywhere, anytime, using a single drop of body fluid and a smartphone. The test takes only 60 seconds, at a low cost, with the result sent immediately to medical professionals.
iMOST Model X-1 uses only three pieces of hardware: a mobile phone, a matchbox-sized adaptor, and a mail stamp-sized sample holder. It is the world’s smallest, simplest, and lowest-cost device for blood cell counting, as well as the device for performing immunoassay, colorimetric assay, cytology and pathology.